COMPANY RESEARCH PROFILE · UPDATED 2026-09-29

Boryung

South Korean pharmaceutical company developing and commercializing cardiovascular, oncology and metabolic medicines.

TICKER003850.KS

HEADQUARTERSSeoul, South Korea

STAGEApproved

ACTIVE TRIALS23

Therapeutic areas

CardiovascularOncologyMetabolic

Selected products and programs

fimasartanBR1019

Linked curated drug profiles

No curated drug entity is linked in the current pilot.

Selected active clinical trials

A Clinical Trial to Evaluate the Safety and Efficacy of Olanzapine Titration Schedule in Patients With Schizophrenia

Phase 2 · Recruiting · Schizophrenia

A Study to Compare and Evaluate the Pharmacokinetic Characteristics and the Safety Between Administration of BR2021 and BR2021-1

Phase 1 · Recruiting · Metastatic Adenocarcinoma of the Pancreas

A Bioequivalence Study to Evaluate Pharmacokinetics and Safety of BR2022 and BR2022-1 in Patients With Deleterious or Suspected Deleterious Germline BRCA-Mutated Advanced Ovarian Cancer

Phase 1 · Recruiting · Ovarian Cancer

A Study to Evaluate the Pharmacokinetics and Safety Between "BR3006" and Co-administration of "BR3006A", "BR3006B", and "BR3006C" in Healthy Adult Volunteers (Fasting)

Phase 1 · Recruiting · Diabetes Mellitus

A Study to Evaluate the Pharmacokinetics and Safety Between "BR3006" and Co-administration of "BR3006A", "BR3006B", and "BR3006C" in Healthy Adult Volunteers (Fed)

Phase 1 · Recruiting · Diabete Mellitus

A Phase IV Clinical Trial to Compare the Efficacy and Safety of Metformin+Sodium-Glucose Cotransporter 2 Inhibitor(SGLT2-i)+Thiazolidinedione (TZD) in Patients With Type 2 Diabetes

Phase 4 · Recruiting · Type 2 Diabetes

Selected patent records

No linked FDA Orange Book patent record was found for the selected products.

Primary and company sources

Company and pipeline information can change. Verify material decisions against the linked primary sources.

Evidence & limits

Source: Open the source record

Record identifier: /companies/boryung/
Event / action date: Not separately retained
Source update date: Not separately retained
Platform retrieval / processing date: Not separately retained

What it supports. Connections found through the catalog, identifiers, or name and alias matching, with source links where retained.

Limits. A company association is not proof of ownership or sponsorship of every linked record. Product, substance, parent-company, and subsidiary relationships may differ.

Connection basis. Catalog, identifier, or normalized name association. Product and company connections are research leads, not ownership determinations.

What this record means · Report an issue with this record